首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Increased sensitivity in detecting renal impairments by quantitative measurement of marker protein excretion compared to detection of pathological particles in urine sediment analysis.
【24h】

Increased sensitivity in detecting renal impairments by quantitative measurement of marker protein excretion compared to detection of pathological particles in urine sediment analysis.

机译:与尿沉渣分析中病理颗粒的检测相比,定量检测标记蛋白的排泄可提高检测肾脏损害的灵敏度。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Positive test strip results, pathological particles in urine and the presence of proteinuria are common findings in nephropathies. A comparison between these methods and renal biopsies became available with the introduction of quantitative measurement of marker proteins (albumin, transferrin, IgG, alpha(1)-microglobulin, retinol binding protein, alpha(2)-macroglobulin, Bence Jones proteins) and standardised urine sediment analysis by flow cytometry or microscopy. METHODS: A total of 400 urine samples were examined using marker protein patterns, test strips and quantitative sediment analyses. RESULTS: Results from standardised urine sediment analyses were compared with the excretion of renal marker proteins. Increased erythrocyte and leukocyte counts in urine were observed in only 29% and 39% of the samples for which pathological protein excretion was found. The sensitivity in detecting pathological particles in urine sediment, such as casts and/or dysmorphic erythrocytes, was only 19%. Renal biopsies from 65 patients who were classified as pathological were compared with proteinuria and sediment analyses. Increased excretion of marker proteins was found in all cases, whereas only 41% of the cellular urine sediments showed pathological results. CONCLUSIONS: Quantitative measurement of marker proteins from both the glomerular and tubular sides should be used upfront as screening parameters for the early detection of renal disorders.
机译:背景:阳性试纸结果,尿液中的病理性颗粒和蛋白尿的存在是肾病的常见发现。通过引入定量测量标记蛋白(白蛋白,转铁蛋白,IgG,α(1)-微球蛋白,视黄醇结合蛋白,α(2)-巨球蛋白,Bence Jones蛋白),可以将这些方法与肾脏活检进行比较通过流式细胞仪或显微镜对尿沉渣进行分析。方法:使用标记蛋白模式,试纸条和定量沉积物分析对400份尿液样本进行检查。结果:将标准化尿沉渣分析的结果与肾脏标志物蛋白的排泄进行了比较。仅在发现病理性蛋白质排泄的样品中,只有29%和39%的尿液中的红细胞和白细胞计数增加。检测尿沉渣中的病理性颗粒(例如管型和/或畸形红细胞)的灵敏度仅为19%。将65例分类为病理学的患者的肾脏活检与蛋白尿和沉积物分析进行了比较。在所有情况下都发现标记蛋白的排泄增加,而仅41%的细胞尿液沉积物显示出病理结果。结论:应从肾小球和肾小管两侧定量检测标记蛋白,作为早期发现肾脏疾病的筛选参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号